Liu Kaitai, Wan Juefeng, Bei Yanping, Chen Xue, Lu Miaozhen
Department of Radiation Oncology, Lihuili Hospital, Ningbo Medical Center, No. 57, Xing'Ning Road, Ningbo, 315041, China.
Department of Radiation Oncology, Fudan University Shanghai Cancer Center, Shanghai, China.
Pathol Oncol Res. 2017 Oct;23(4):881-887. doi: 10.1007/s12253-017-0198-2. Epub 2017 Jan 23.
The clinicopathological characteristics and prognosis of gastric mucinous adenocarcinoma (MAC) and signet ring cell carcinoma (SRC) are still controversial. We designed our study to evaluate the clinicopathologic features and prognosis of MAC, SRC and ordinary gastric adenocarcinoma (OGAC) by analyzing the Surveillance, Epidemiology, and End Results (SEER)-registered database. The 5-year overall survival (OS) of patients with SRC was significantly lower than that of patients with MAC (P = 0.001) and OGAC (P < 0.001), and there was no significant difference in 5-year OS between MAC and OGAC (P = 0.804). Furthermore, there were no significant differences of 5-years OS among these three groups at stage I, II and III (all P > 0.05) and no significant difference between MAC and OGAC at stage IV (P = 0.110). Patients in SRC group had significantly worse survival than those in MAC and OGAC at stage IV (both P = 0.008), with 5-year OS of 3.3%, 5.8%, and 5.8%, respectively. However, the histological type was not found to be an independent prognostic factor of gastric cancer according to the multivariate analysis with Cox regression.
胃黏液腺癌(MAC)和印戒细胞癌(SRC)的临床病理特征及预后仍存在争议。我们设计本研究,通过分析监测、流行病学和最终结果(SEER)注册数据库,来评估MAC、SRC和普通胃腺癌(OGAC)的临床病理特征及预后。SRC患者的5年总生存率(OS)显著低于MAC患者(P = 0.001)和OGAC患者(P < 0.001),MAC和OGAC的5年OS无显著差异(P = 0.804)。此外,这三组在Ⅰ、Ⅱ和Ⅲ期的5年OS无显著差异(所有P > 0.05),在Ⅳ期MAC和OGAC之间也无显著差异(P = 0.110)。在Ⅳ期,SRC组患者的生存率显著低于MAC组和OGAC组患者(均P = 0.00)
,5年OS分别为3.3%、5.8%和5.8%。然而,根据Cox回归多因素分析,组织学类型并非胃癌的独立预后因素。